News News

CONTACT:

Sirnaomics, Inc.
Michael Molyneaux MD MBA
Chief Medical Officer
michaelmolyneaux@sirnaomics.com

ICR Healthcare

Investors:
Stephanie Carrington
Tel: +1 646 277 1282
Stephanie.Carrington@icrinc.com

Media: James Heins
Tel: +1 203 682 8251
James.Heins@icrinc.com

Sirnaomics News Placeholder 04
June 25, 2012 Sirnaomics Received NIH SBIR Grant for Developing Its Scarless Wound Healing siRNA Therapeutics

Sirnaomics announced today that the company has been awarded another NIH SBIR (Small Business Innovation Research) grant for developing its small interfering RNA (siRNA) therapeutic product STP705 to improve skin wound healing with minimized scar formation.

Sirnaomics News Placeholder 03
February 28, 2012 Dr. Patrick Lu Presents at AsiaTIDES Conference

The 4th AsiaTIDES annuel conference, being held in Tokyo, Japan from February 28 to March 1, 2012, continues to be the premier forum to get a comprehensive update, meet key players and increase knowledge of the oligonucleotide- and peptide-based therapeutics fields.

Sirnaomics News Placeholder 02
August 6, 2010 Governor Martin O’Malley Announces Appointments to Various Boards and Commissions

Governor Martin O’Malley today announced appointments to the Maryland Council for Educator Effectiveness; the University System of Maryland Board of Regents; the Blue Ribbon Commission on Transportation Funding.

Sirnaomics News Placeholder 01
June 24, 2010 Sirnaomics Aims to Move Wound-Healing Drug into Phase I Next Year

Having put on the backburner its one-time lead drug-development program in ocular neovascularization disorders, Sirnaomics is now focusing on an siRNA-based treatment for scarless wound healing and anticipates moving the drug into phase I testing.

1 5 6 7